Mesenchymal stem cells (MSCs) have become one of the most widely studied tools in regenerative medicine because of their ability to support tissue repair, regulate inflammation, and communicate with damaged or stressed cells. These cells are being explored across a wide range of conditions, including inflammatory disorders, neurological disease, cardiovascular injury, lung disease, wound healing, and immune-related conditions.
In this review published in Frontiers in Bioengineering and Biotechnology, researchers examined how MSC therapies are moving from laboratory and preclinical research toward real-world clinical use. The review highlights the biological mechanisms that make MSCs promising, the clinical evidence supporting their use, and the innovations helping improve their consistency, delivery, and therapeutic potential.
Why MSCs Are Important in Regenerative Medicine
MSCs are multipotent cells, meaning they can develop into several types of connective tissue cells, including bone, cartilage, and fat cells. However, researchers now believe that many of their most important therapeutic effects come less from directly replacing damaged tissue and more from the signals they release.
According to the review, MSCs primarily act through paracrine signaling, which means they secrete bioactive molecules that influence nearby cells and tissues. These secreted factors include growth factors, cytokines, extracellular vesicles, and exosomes that can help reduce inflammation, encourage blood vessel formation, and support tissue repair.
This signaling ability is one reason MSCs are so attractive in regenerative medicine. Instead of targeting only one pathway, MSCs may influence multiple healing processes at the same time, including immune regulation, tissue remodeling, cellular survival, and repair-related communication.
How MSCs Support Healing
The review describes several ways MSCs may help support damaged or inflamed tissues. One of the most important is immunomodulation. MSCs can interact with immune cells and help shift the body away from an overly inflammatory state. The authors explain that MSCs may reduce T-cell activity, support regulatory immune responses, and influence macrophages toward a more anti-inflammatory phenotype.
MSCs also release trophic factors that support tissue repair. These include molecules involved in angiogenesis, which is the formation of new blood vessels, as well as factors that help reduce cell death and preserve tissue structure. This combination of immune regulation and tissue support makes MSCs useful to study in conditions where inflammation and tissue damage occur together.
Another exciting mechanism discussed in the review is mitochondrial transfer. Researchers have found that MSCs may donate healthy mitochondria to injured cells through small cellular connections called tunneling nanotubes. Since mitochondria help produce energy inside cells, this transfer may help restore cellular function in tissues affected by injury or stress. The authors highlight this as an emerging mechanism that expands the therapeutic potential of MSCs beyond traditional cell signaling.
Clinical Areas Being Studied
The article reviews clinical and preclinical evidence across several major areas of medicine. In autoimmune and inflammatory diseases, MSCs are being investigated for their ability to regulate immune activity and reduce inflammation. The review discusses clinical evidence involving conditions such as graft-versus-host disease, Crohn’s disease, and rheumatoid arthritis.
The authors also describe the relevance of MSCs in neurological disorders, where MSC-derived factors and exosomes may support neuroprotection, nerve repair, and inflammation control. In cardiovascular research, MSCs are being studied for their potential to support heart tissue repair, reduce scarring, and improve recovery after injury. The review also notes growing research involving lung conditions, including acute respiratory distress syndrome and severe inflammatory respiratory illness.
One particularly relevant area discussed in the review is the use of umbilical cord-derived MSCs. The authors note that UC-MSCs have been studied for their ability to reduce inflammatory signaling and support lung tissue repair in severe respiratory conditions. This reinforces the broader interest in birth tissue-derived MSCs as accessible and biologically active tools in regenerative medicine.
Moving Toward More Advanced MSC Therapies
As MSC research continues to develop, scientists are working on ways to make these therapies more precise and consistent. The review highlights several emerging strategies, including genetic engineering, biomaterial scaffolds, 3D bioprinting, artificial intelligence, and advanced manufacturing methods. These innovations may help improve cell survival, optimize dosing, personalize treatment selection, and make MSC products more standardized.
For example, biomaterial scaffolds may help MSCs survive longer and remain active in damaged tissue environments. Genetic engineering may allow researchers to enhance specific MSC functions, while AI-driven platforms may help identify which cell characteristics are most likely to produce strong therapeutic effects. Together, these technologies are helping move MSC therapy from early research toward more reliable clinical applications.
Why This Research Matters
This review is important because it looks at MSC therapy from both a scientific and translational perspective. In other words, it does not only ask whether MSCs show potential, but also how researchers can make that potential more practical, consistent, and clinically useful.
The authors emphasize that MSC therapy is moving forward through a combination of mechanistic research, clinical evidence, manufacturing improvements, and new technology. While continued research is still needed, the overall direction of the field is promising. By improving how MSCs are produced, delivered, and evaluated, researchers are working to make regenerative medicine therapies more dependable and accessible.
A Promising Path Forward for Regenerative Medicine
Mesenchymal stem cells continue to represent one of the most exciting areas of regenerative medicine research. Their ability to regulate inflammation, release healing signals, support tissue repair, and interact with damaged cells gives them broad potential across many medical fields.
As this review explains, the future of MSC therapy will likely depend on combining strong scientific evidence with better standardization, advanced delivery systems, and personalized treatment strategies. With continued innovation, MSC-based therapies may become an increasingly important part of regenerative medicine, helping bridge the gap between laboratory discoveries and real-world patient care.
Source Patel JC, Shukla M, Shukla M. From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence. Front Bioeng Biotechnol. 2025 Jul 30;13:1639439. doi: 10.3389/fbioe.2025.1639439. Available from: https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2025.1639439/full
Related Treatment Pages